Who
Xia Ding
Director
Company insider
Files Form 4 as: Director, USANA Health Sciences.
In numbers
- Trades disclosed
- 77
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $40K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 25 Oct 2021
- Last trade
- 23 Jul 2026
- Last filed
- 27 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,632 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $13K604 at $20.92 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,632 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,632 at $0.00 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,632 | filing |
| 23 Jul 2026filed 27 Jul 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $13K604 at $20.92 | filing |
| 7 May 2026filed 11 May 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,527 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —6,527 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,057 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $7,523391 at $19.24 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,057 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,057 at $0.00 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,057 | filing |
| 23 Apr 2026filed 27 Apr 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $7,523391 at $19.24 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,058 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $8,824392 at $22.51 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,058 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health Sciencesoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,058 at $0.00 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code M | —1,058 | filing |
| 22 Jan 2026filed 26 Jan 2026 | USNA USANA Health SciencesPharmaceuticals | SEC FORM 4 Code F | $8,824392 at $22.51 | filing |
News
No headline names them, or the companies they trade most, lately.